Project Grant HT94252410581
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$806K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The University of California, San Francisco will receive $565,250 from the Department of the Army Medical Command under a three-year Project Grant award to investigate mutation burden in normal skin as a predictor of melanoma risk. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine and other health issues. Specifically,...
The Regents of the University of California, San Francisco will receive $565,250 from the Department of the Army Medical Command through May 2025 under a Project Grant award from the Military Medical Research and Development program (CFDA 12.420). The grant will fund research investigating mutation burden in normal skin as a predictor of melanoma risk. Specifically, the University of California, San Francisco will conduct basic, applied, and advanced biomedical research to transform military and...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $959,882.00 to The Regents of the University of California, San Francisco (UCSF) to establish and overcome the mechanisms of liver metastasis-induced systemic tumor immune tolerance and immunotherapy resistance in melanoma. The 3-year research project aims to investigate fundamental biological processes and develop new therapeutic approaches to enhance the...
The Regents of the University of California, San Francisco will receive $564,954 under a three-year Project Grant from the Department of the Army Medical Command to identify novel therapeutic strategies for metastatic uveal melanoma through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $302,228 project grant to The Regents of the University of California, San Francisco to support research on "Establishing and Overcoming the Mechanisms of Liver Metastasis-Induced Systemic Tumor Immune Tolerance and Immunotherapy Resistance in Melanoma." The 3-year grant project, running from September 30, 2023 to September 29, 2026, will investigate the biological mechanisms by...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $339,209.00 to The Regents of the University of California, San Francisco (UCSF) to establish and overcome the mechanisms of liver metastasis-induced systemic tumor immune tolerance and immunotherapy resistance in melanoma. The 3-year research project, with a start date of September 30, 2023 and completion date of September 29, 2026, will investigate biological and...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...